World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
85
Citations
31663
World Ranking
14471
National Ranking
7317

Overview

Ann D. Thor is affiliated with the University of Colorado Anschutz Medical Campus in the United States. Their research primarily focuses on medical and molecular biological aspects of cancer, with a total of 22 publications in Medicine and 14 in Biochemistry, Genetics, and Molecular Biology.

The scientist's work extensively covers oncology, genetics, and molecular biology, reflecting in subfield contributions including:

  • Oncology
  • Genetics
  • Molecular Biology
  • Radiology, Nuclear Medicine and Imaging
  • Cancer Research

Main topics of research by Ann D. Thor include:

  • Cancer-related Molecular Pathways
  • Estrogen and related hormone effects
  • HER2/EGFR in Cancer Research
  • Monoclonal and Polyclonal Antibodies Research
  • Metabolism, Diabetes, and Cancer
  • Cancer Risks and Factors
  • Chronic Lymphocytic Leukemia Research

Ann D. Thor has published in several scientific journals with frequent contributions to:

  • Cancer Research
  • Cancer Drug Resistance
  • Molecular Therapy - Oncolytics
  • Breast Cancer Research
  • Clinical Cancer Research

Recent published papers include:

  • Targeted lapatinib anti-HER2/ErbB2 therapy resistance in breast cancer: opportunities to overcome a difficult problem, 2020, Cancer Drug Resistance
  • Upregulation of endogenous TRAIL-elicited apoptosis is essential for metformin-mediated antitumor activity against TNBC and NSCLC, 2021, Molecular Therapy - Oncolytics
  • Preventing ovariectomy-induced weight gain decreases tumor burden in rodent models of obesity and postmenopausal breast cancer, 2022, Breast Cancer Research
  • Exogenous Thyroid Hormone Is Associated with Shortened Survival and Upregulation of High-Risk Gene Expression Profiles in Steroid Receptor-Positive Breast Cancers, 2020, Clinical Cancer Research
  • HER3 functions as an effective therapeutic target in triple negative breast cancer to potentiate the antitumor activity of gefitinib and paclitaxel, 2023, Cancer Cell International

Frequent collaborators of Ann D. Thor include:

  • Bolin Liu
  • Reema S. Wahdan-Alaswad
  • Susan M. Edgerton
  • Sanbao Ruan
  • Hui Lyu

Best Publications

  • Revision of the American Joint Committee on Cancer Staging System for Breast Cancer

    S. Eva Singletary;Craig Allred;Pandora Ashley;Lawrence W. Bassett

  • Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999.

    Fitzgibbons Pl;Page Dl;Weaver D;Thor Ad

  • Prognostic Factors in Breast Cancer

    Patrick L. Fitzgibbons;Patrick L. Fitzgibbons;David L. Page;Donald Weaver;Ann D. Thor

  • Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells

    Zhiqiang Zou;Anthony Anisowicz;Mary J. C. Hendrix;Ann Thor

  • c-erbB-2 Expression and Response to Adjuvant Therapy in Women with Node-Positive Early Breast Cancer

    Hyman B. Muss;Ann D. Thor;Donald A. Berry;Timothy Kute

  • Accumulation of p53 Tumor Suppressor Gene Protein: An Independent Marker of Prognosis in Breast Cancers

    Ann D. Thor;Dan H. Moore;Susan M. Edgerton;Ernest S. Kawasaki

  • Association of Vascular Endothelial Growth Factor and Vascular Endothelial Growth Factor Receptor-2 Genetic Polymorphisms With Outcome in a Trial of Paclitaxel Compared With Paclitaxel Plus Bevacizumab in Advanced Breast Cancer: ECOG 2100

    Bryan P. Schneider;Molin Wang;Milan Radovich;George W. Sledge

  • Loss of Heterozygosity in Normal Tissue Adjacent to Breast Carcinomas

    Guoren Deng;You Lu;Galina Zlotnikov;Ann D. Thor

  • HER2 and Response to Paclitaxel in Node-Positive Breast Cancer

    Daniel F. Hayes;Ann D. Thor;Lynn G. Dressler;Donald Weaver

  • erbB-2, p53, and Efficacy of Adjuvant Therapy in Lymph Node-Positive Breast Cancer

    Ann D. Thor;Ann D. Thor;Donald A. Berry;Daniel R. Budman;Hyman B. Muss

  • ERBB2 amplification in breast cancer analyzed by fluorescence in situ hybridization.

    Olli-P. Kallioniemi;Anne Kallioniemi;Wayne Kurisu;Ann Thor

  • Metformin inhibits breast cancer cell growth, colony formation and induces cell cycle arrest in vitro

    Irina N. Alimova;Bolin Liu;Zeying Fan;Susan M. Edgerton

  • Metformin induces unique biological and molecular responses in triple negative breast cancer cells.

    Bolin Liu;Zeying Fan;Susan M. Edgerton;Xin-Sheng Deng

  • Role of the androgen receptor in breast cancer and preclinical analysis of enzalutamide.

    Dawn R Cochrane;Sebastián Bernales;Britta M Jacobsen;Diana M Cittelly

  • The art and science of cytopathology: Richard M. DeMay, MD. Chicago IL, ASCP Press, 1996, 2 vol set, 1,289 pages, $285

    Ann D Thor

  • Reconstitution of Caspase 3 Sensitizes MCF-7 Breast Cancer Cells to Doxorubicin- and Etoposide-induced Apoptosis

    Xiao He Yang;Todd L. Sladek;Xuesong Liu;Bryn R. Butler

  • p53 gene mutations and protein accumulation in human ovarian cancer

    Jolanta Kupryjanczyk;Ann D. Thor;Roberta Beauchamp;Victor Merritt

  • Staging system for breast cancer: revisions for the 6th edition of the AJCC Cancer Staging Manual.

    S.Eva Singletary;Craig Allred;Pandora Ashley;Lawrence W Bassett

  • Expression of ras oncogene p21 in prostate cancer.

    Michael V. Viola;Frank Fromowitz;Sheila Oravez;Swati Deb

  • Loss of the retinoblastoma tumor-suppressor gene in parathyroid carcinoma

    Vincent L. Cryns;Ann Thor;Hong Ji Xu;Shi Xue Hu

Frequent Co-Authors

Jeffrey Schlom
Jeffrey Schlom National Institutes of Health
Dan H. Moore
Dan H. Moore University of California, San Francisco
Jennifer K. Richer
Jennifer K. Richer University of Colorado Anschutz Medical Campus
Donald A. Berry
Donald A. Berry The University of Texas MD Anderson Cancer Center
Daniel F. Hayes
Daniel F. Hayes University of Michigan–Ann Arbor
David W. Yandell
David W. Yandell Harvard University
Larry Norton
Larry Norton Memorial Sloan Kettering Cancer Center
George W. Sledge
George W. Sledge Stanford University
Robert E. Scully
Robert E. Scully Harvard University
Kathy D. Miller
Kathy D. Miller Indiana University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medicine is just one pathway in the evolving healthcare landscape. There are a variety of related online degrees that open doors to rewarding roles in healthcare administration, leadership, pharmacy, and health information management.

For students interested in management positions, cheapest online mha programs can offer a flexible, affordable route to a Master of Healthcare Administration, equipping graduates with key leadership and organizational skills.

Nurses who seek to advance their careers can consider the cheapest dnp programs online, allowing them to earn a Doctor of Nursing Practice and prepare for roles in clinical leadership, academia, and advanced practice.

Those with an interest in pharmaceuticals can pursue a pharmacy degree online and gain vital knowledge for pharmacy practice and medication management careers.

Technology-focused students may opt for a bachelor of health information management online, preparing them to manage medical data and ensure healthcare information integrity.

Each pathway offers unique skills and career opportunities for those passionate about making a difference in healthcare.

Best Scientists Citing Ann D. Thor

Trending Scientists